Palisade Bio (PALI) Assets Growth (1y) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Palisade Bio | 439.25 Mn | 309.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,527.78% |
| Dec 31, 2025 | 1,134.78% |
| Sep 30, 2025 | -25.31% |
| Jun 30, 2025 | -48.20% |
| Mar 31, 2025 | -35.27% |
| Dec 31, 2024 | -22.57% |
| Sep 30, 2024 | -45.30% |
| Jun 30, 2024 | -29.63% |
| Mar 31, 2024 | -17.10% |
| Dec 31, 2023 | -10.85% |
| Sep 30, 2023 | 4.92% |
| Jun 30, 2023 | 134.31% |
| Mar 31, 2023 | 82.78% |
| Dec 31, 2022 | 25.98% |
| Sep 30, 2022 | -0.05% |
| Jun 30, 2022 | -47.78% |
| Mar 31, 2022 | -6.34% |
| Dec 31, 2021 | 314.44% |
| Sep 30, 2021 | 7.28% |
| Jun 30, 2021 | -12.59% |
| Mar 31, 2021 | -21.53% |
| Dec 31, 2020 | -54.15% |
| Sep 30, 2020 | 69.62% |
| Jun 30, 2020 | 385.61% |
| Mar 31, 2020 | 110.16% |
| Dec 31, 2019 | -14.32% |
| Sep 30, 2019 | 15.83% |
| Jun 30, 2019 | -61.86% |
| Mar 31, 2019 | -53.20% |
| Dec 31, 2018 | -44.65% |
| Sep 30, 2018 | -52.31% |
| Jun 30, 2018 | -30.41% |
| Mar 31, 2018 | -38.33% |
| Dec 31, 2017 | -38.58% |
| Sep 30, 2017 | 91.57% |
| Jun 30, 2017 | -0.20% |
| Mar 31, 2017 | 83.63% |
| Dec 31, 2016 | 51.20% |
| Sep 30, 2016 | -60.03% |
| Jun 30, 2016 | -49.59% |
| Mar 31, 2016 | -66.89% |
| Dec 31, 2015 | -49.91% |
| Sep 30, 2015 | -28.20% |
| Jun 30, 2015 | -19.17% |
| Mar 31, 2015 | -14.27% |
| Dec 31, 2014 | 53.73% |
| Sep 30, 2014 | 53.62% |
| Jun 30, 2014 | 136.47% |
| Mar 31, 2014 | 133.10% |
| Dec 31, 2013 | 121.87% |
| Sep 30, 2013 | 70.49% |
| Jun 30, 2013 | 248.68% |
| Mar 31, 2013 | 125.10% |
| Dec 31, 2012 | 114.14% |
| Sep 30, 2012 | 90.90% |
| Jun 30, 2012 | -46.67% |
| Dec 31, 2011 | -61.42% |